You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Histamine H1 Antagonists

Showing 1 - 25 of 2,127
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Exercise, Histamine Trial in Ghent (Placebo: Placebo + exercise training., H1 blockade: H1 receptor antagonist + exercise

Active, not recruiting
  • Exercise
  • Histamine
  • Placebo: Placebo + exercise training.
  • +2 more
  • Ghent, Oost-Vlaanderen, Belgium
    Department of movement and sports sciences, Ghent University, Be
Nov 8, 2022

Histamine Trial in Ghent (Placebo, H1 blockade: Telfast: 180mg Fexofenadine, Resistance training)

Recruiting
  • Histamine
  • Placebo
  • +2 more
  • Ghent, Oost-Vlaanderen, Belgium
    Department of movement and sports sciences, Ghent University, Be
Nov 29, 2023

Primary Aldosteronism Trial in Montréal (Renin measurements)

Not yet recruiting
  • Primary Aldosteronism
  • Renin measurements
  • Montréal, Quebec, Canada
    Hôpital du Sacré-Coeur de Montréal
Oct 30, 2023

Exercise Training, Physical Activity Trial in Gent (Lactose, Fexofenadine Hydrochloride, Famotidine)

Completed
  • Exercise Training
  • Physical Activity
  • Lactose
  • +3 more
  • Gent, Oost-Vlaanderen, Belgium
    Department of Movement and Sports Sciences, Ghent University
Jul 29, 2021

Burns Trial in Shanghai (Cetirizine, Midazolam and Fentanyl)

Recruiting
  • Burns
  • Shanghai, Shanghai, China
    Department of Burn, Ruijin Hospital, Shanghai Jiao Tong Universi
Nov 6, 2023

Cold Urticaria Trial in Worldwide (Dupilumab SAR231893, Placebo, Non sedating H1-antihistamine)

Active, not recruiting
  • Cold Urticaria
  • Dupilumab SAR231893
  • +2 more
  • San Diego, California
  • +34 more
Nov 15, 2022

Concomitant Intranasal Antihistamine and Corticosteroid in

Recruiting
  • Allergic Rhinitis
  • concomitant intranasal antihistamine and corticosteroid
  • Incheon, Korea, Republic of
    Gachon University Gil Medical Center
Jan 23, 2023

Cancer Trial in Rotterdam (Dexamethasone, H1 Antihistaminics)

Not yet recruiting
  • Cancer
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus MC
Nov 1, 2023

SARS-CoV-2 Infection

Recruiting
  • COVID-19
  • Terrassa, Barcelona, Spain
  • +1 more
Aug 15, 2022

Stress Ulcer Drugs and Clinical Outcomes in Acute Anterior

Not yet recruiting
  • Acute Ischemic Stroke
    • Fuzhou, Fujian, China
    • +18 more
    Apr 26, 2023

    Cancer Trial in Halifax (Ranitidine)

    Unknown status
    • Cancer
    • Halifax, Nova Scotia, Canada
      Nova Scotia Health Authority
    Mar 8, 2019

    Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

    Active, not recruiting
    • Breast Neoplasms
    • Chuo Ku, Japan
    • +1 more
    Dec 19, 2022

    Pruritus Trial in Leuven (Desloratadine Single Dose, Levocetirizine Single Dose, Desloratadine Fourfold Dose)

    Completed
    • Pruritus
    • Desloratadine Single Dose
    • +3 more
    • Leuven, Belgium
      Center for Clinical Pharmacology
    May 25, 2020

    Peanut Allergy Trial in Hamilton (Peanut protein, Oat flour, Antihistamine)

    Completed
    • Peanut Allergy
    • Peanut protein
    • +2 more
    • Hamilton, Ontario, Canada
      McMaster University
    Jan 18, 2022

    Itch Trial in Aalborg (Anti-histamine cream 1 hour, Local anesthetic cream 1 hour)

    Enrolling by invitation
    • Itch
    • Anti-histamine cream 1 hour
    • Local anesthetic cream 1 hour
    • Aalborg, Aalborg Ø, Denmark
      Aalborg University
    Jul 25, 2022

    Hypersensitivity Trial (desloratadine, levocetirizine, Desloratadine tablet)

    Completed
    Has Results
    • Hypersensitivity
    • (no location specified)
    Feb 7, 2022

    Allergic Rhinitis Trial in Den Haag (Acupuncture, Antihistamine nasal spray)

    Not yet recruiting
    • Allergic Rhinitis
    • Acupuncture
    • Antihistamine nasal spray
    • Den Haag, Zuid-Holland, Netherlands
      Mermaid Medicine®
    Feb 1, 2023

    Relapsing Multiple Sclerorsis, Multiple Sclerosis, Primary Progressive Trial in Worldwide (Ocrelizumab, Lumbar Puncture,

    Active, not recruiting
    • Relapsing Multiple Sclerorsis
    • Multiple Sclerosis, Primary Progressive
    • Palo Alto, California
    • +16 more
    Jul 26, 2022

    Lymphoma, Large B-Cell, Diffuse Trial in China (Rituximab IV, Rituximab SC, Cyclophosphamide)

    Active, not recruiting
    • Lymphoma, Large B-Cell, Diffuse
    • Rituximab IV
    • +7 more
    • Beijing, China
    • +9 more
    Apr 6, 2022

    Multiple Sclerosis, Infusion Reaction Trial in Portland (antihistamine)

    Active, not recruiting
    • Multiple Sclerosis
    • Infusion Reaction
    • Portland, Oregon
      Providence Neurological Specialties West
    Jan 10, 2022

    ß1-adrenergic Antagonists on Nociceptive-Level Index Variation

    Completed
    • Nociception During Anesthesia in Patients Taking β1-adrenergic Antagonist Chronic Treatment
    • standardized noxious stimulus under general anesthesia.
    • Montréal-Est, Quebec, Canada
      Hopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montre
    Aug 31, 2020

    COVID -19 Trial in Puducherry (Oral Antibiotic, Antihistamine, Anti-inflammatory, Multivitamins, Oral low dose steroid,

    Completed
    • COVID -19
    • Oral Antibiotic, Antihistamine, Anti-inflammatory, Multivitamins
    • +3 more
    • Puducherry, India
      ONLINE
    Jun 22, 2021

    Circulating Tumor Cell, Metastatic Prostate Cancer Trial in Netherlands (Cabazitaxel, Antihistamine, Corticosteroid)

    Active, not recruiting
    • Circulating Tumor Cell
    • Metastatic Prostate Cancer
    • Delft, Netherlands
    • +8 more
    Aug 19, 2021

    Efficacy and Safety Trial in Beijing (Clemastine, Saline Solution)

    Completed
    • Efficacy and Safety
    • Beijing, Beijing, China
      Cardiovascular Institute and Fuwai Hospital, CAMS&PUMC
    Jan 10, 2020

    Seasonal Allergic Rhinitis Trial in China (LP-003 dose 1, LP-003 dose 2, Placebo)

    Recruiting
    • Seasonal Allergic Rhinitis
    • LP-003 dose 1
    • +2 more
    • Beijing, Beijing, China
    • +16 more
    Sep 18, 2023